COVID-19 pandemic
Bloomington-based HealthPartners announces that they are seeking 1,500 patients for the phase 3 trials for AstraZeneca's COVID-19 vaccine.
Sources: The Star-Tribune
Changes
- Bloomington-based HealthPartners announces that they are seeking 1,500 patients for the phase 3 trails for AstraZeneca.
- Bloomington-based HealthPartners announces that they are seeking 1,500 patients for the phase 3 trials for AstraZeneca.
- Bloomington-based HealthPartners announces that they are seeking 1,500 patients for the phase 3 trials for AstraZeneca's COVID-19 vaccine.
Related
Ukraine secures 12 million doses of the vaccine developed by AstraZeneca and Novavax.